Afatinib-loaded immunoliposomes functionalized with cetuximab: A novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer-Reference-Cited by-同舟云学术

Afatinib-loaded immunoliposomes functionalized with cetuximab: A novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer

Published:2019-04 Issue: Volume:560 Page:126-135
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Lu Xiaoyan,Liu Sha^ORCID,Han Meishan,Yang Xiucheng,Sun Kaoxiang,Wang Hongbo,Mu Hongjie,Du Yuan,Wang Aiping,Ni Ling,Zhang Chunyan

Funder

Natural Science Foundation of Shandong Province

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. (S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1;Dai;J. Exp. Clin. Cancer Res.,2017

2. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo;Duan;Int. J. Nanomedicine,2018

3. Immunoliposomes: a review on functionalization strategies and targets for drug delivery;Eloy;Colloids Surf B Biointerfaces,2017

4. FDA, U.S., 2013. Approved Drugs: Afatinib.pharmacology/toxicology NDA review and evaluation, in: Dubravka Kufrin , S.L.W. (Ed.).

5. FDA, U.S., 2018. SUPPLEMENT APPROVAL.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model;International Journal of Pharmaceutics;2024-08

3. Nanoparticle-based targeted therapy through EGFR tyrosine kinase inhibitors and their recent advances in lung cancer therapy;Exploration of Medicine;2024-07-14

4. Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles;Life;2024-04-10

5. EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer;International Journal of Nanomedicine;2024-04